673 related articles for article (PubMed ID: 11032757)
21. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.
Baghdassarian N; Catallo R; Mahly MA; Ffrench P; Chizat F; Bryon PA; Ffrench M
Exp Cell Res; 1998 May; 240(2):263-73. PubMed ID: 9596999
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators.
Cerda SR; Mustafi R; Little H; Cohen G; Khare S; Moore C; Majumder P; Bissonnette M
Oncogene; 2006 May; 25(22):3123-38. PubMed ID: 16434969
[TBL] [Abstract][Full Text] [Related]
23. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
Damiens E; El Yazidi I; Mazurier J; Duthille I; Spik G; Boilly-Marer Y
J Cell Biochem; 1999 Sep; 74(3):486-98. PubMed ID: 10412049
[TBL] [Abstract][Full Text] [Related]
24. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
Gong J; Ammanamanchi S; Ko TC; Brattain MG
Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
[TBL] [Abstract][Full Text] [Related]
26. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
Mann DJ; Higgins T; Jones NC; Rozengurt E
Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
[TBL] [Abstract][Full Text] [Related]
28. Analysis of cyclin D1 and CDK expression in colonic polyps containing neoplastic foci: a study of proteins extracted from paraffin sections.
Izawa H; Yamamoto H; Ikeda M; Ikeda K; Fukunaga H; Yasui M; Ikenaga M; Sekimoto M; Monden T; Matsuura N; Monden M
Oncol Rep; 2002; 9(6):1313-8. PubMed ID: 12375040
[TBL] [Abstract][Full Text] [Related]
29. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma.
Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG
Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
Al-Aynati MM; Radulovich N; Ho J; Tsao MS
Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
[TBL] [Abstract][Full Text] [Related]
31. K252a inhibits the phosphorylation of pRb without changing the levels of G1 cyclins and Cdk2 protein in human hepatoma cells.
Nakayama T; Hashimoto Y; Kaneko Y; Kurokawa K
Biochem Biophys Res Commun; 1996 Jul; 224(1):180-3. PubMed ID: 8694809
[TBL] [Abstract][Full Text] [Related]
32. NA22598, a novel antitumor compound, reduces cyclin D1 levels, arrests cell cycle at G1 phase, and inhibits anchorage-independent growth of human tumor cells.
Kawada M; Kuwahara A; Nishikiori T; Mizuno S; Uehara Y
Exp Cell Res; 1999 Jun; 249(2):240-7. PubMed ID: 10366423
[TBL] [Abstract][Full Text] [Related]
33. Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1.
Gius DR; Ezhevsky SA; Becker-Hapak M; Nagahara H; Wei MC; Dowdy SF
Cancer Res; 1999 Jun; 59(11):2577-80. PubMed ID: 10363976
[TBL] [Abstract][Full Text] [Related]
34. Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells.
Tomida A; Suzuki H; Kim HD; Tsuruo T
Oncogene; 1996 Dec; 13(12):2699-705. PubMed ID: 9000144
[TBL] [Abstract][Full Text] [Related]
35. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
[TBL] [Abstract][Full Text] [Related]
36. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.
Lundberg AS; Weinberg RA
Mol Cell Biol; 1998 Feb; 18(2):753-61. PubMed ID: 9447971
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth.
Driscoll B; Wu L; Buckley S; Hall FL; Anderson KD; Warburton D
Am J Physiol; 1997 Nov; 273(5):L941-9. PubMed ID: 9374720
[TBL] [Abstract][Full Text] [Related]
38. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1.
Peterson SR; Gadbois DM; Bradbury EM; Kraemer PM
Cancer Res; 1995 Oct; 55(20):4651-7. PubMed ID: 7553644
[TBL] [Abstract][Full Text] [Related]
39. p16INK4 mediates contact-inhibition of growth.
Wieser RJ; Faust D; Dietrich C; Oesch F
Oncogene; 1999 Jan; 18(1):277-81. PubMed ID: 9926944
[TBL] [Abstract][Full Text] [Related]
40. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression.
Tam SW; Theodoras AM; Shay JW; Draetta GF; Pagano M
Oncogene; 1994 Sep; 9(9):2663-74. PubMed ID: 8058330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]